Biovision will Explore Ways to Identify and Fund Disruptive Innovation in Healthcare
News Feb 19, 2014
Biovision is launching this years’ registration campaign and its call for applications for innovative projects and companies. This year’s event will take place in Lyon, France, on June 5 and 6, 2014.
The World Life Sciences forum attracts a wide range of innovative companies seeking funding, partners and broader industry exposure. This year, it will bring together international decision-makers from the academic, policy-making, civil society and private sectors to discuss the effects of ‘disruptive innovation’.
New in 2014, two special sessions will also raise awareness and educate the general public on the scientific issues of tomorrow.
High quality panelists from all over the world will debate the two key future-oriented themes of 2014: ‘immunotherapies’ and ’healthy ageing’.
Immunotherapy is a key topic at Biovision 2014. Today, better knowledge of the immune system is driving considerable advances in diagnostics, prevention and therapeutics for the treatment of infectious or chronic diseases and cancer. What are these solutions and how can they be developed to face the new challenges in human health care? How can we ensure that the greatest number of people can access these innovations via holistic or personalized medicine?
The subject of healthy ageing spans health care policy, access to care, e-health care and innovative technologies. Worldwide, the number of people over 65 is set to triple between now and 2050, rising from 531 million to 1.5 billion. By 2050, the majority of people in Japan, South Korea and Germany are expected to be older than 50 (source: Pew Research Center). Speakers at Biovision will discuss the collective approaches developed in response to population ageing and a range of individual solutions that can help citizens to ’age well’.
Funding for health care projects takes center stage at Biovision 2014
By popular demand, the Biovision Investor Conference is returning for a second edition this year. Dedicated to funding for innovative businesses, it will connect start-ups, growth companies and mid-sized businesses with financial and industry partners in a series of discussions and meetings.
Start-ups - selected by a committee co-chaired this year by Tim Haines, a partner at Abingworth, London, UK and Alexia Perouse, Associate Director for Life Sciences at Omnes Capital, Paris, France - will introduce their respective businesses at two dedicated sessions.
Biovision, in partnership with world-class bio-cluster Lyonbiopole, is also organizing the second Catalyzer conference, which showcases innovative collaborative projects. Two sessions will provide increased exposure for immunology and ’healthy aging’ project owners and offer new opportunities to meet with potential partners.
“Biovision reflects a desire to move from thoughts to action,” explains Alain Merieux, chairman of the Fondation pour l'Universite de Lyon and the Institut Merieux. “With this in mind, it is a place where multiple stakeholders can meet, be they from academia, the policy or private sectors, or from civil society - which also needs to understand the complexity of our professional challenges.”
Endorsed projects and companies who respectively wish to participate to the Catalyzer and Investor Conference will be announced online in early March. The final list of project holders and companies selected to present at Biovision will be announced on April 21 for Catalyzer and on May 5 for the Investor Conference.
Computational Model Underlines Need for Personalised Approach to SepsisNews
A computational model of the human immune system has enabled researchers to explore the challenges of tackling sepsis.READ MORE
Allergies and Asthma Possibly Linked to Female HormonesNews
Fluctuations in female sex hormones could play a role in the development of allergies and asthma, a major review of evidence suggests. Analysis of studies involving more than 500,000 women highlights a link between asthma symptoms and key life changes such as puberty and menopause. Further investigation could help explain why asthma is more common in boys than girls in childhood, but more common in teenage girls and women following puberty.READ MORE
Comments | 0 ADD COMMENT
Next Gen Regenerative Medicine & Tissue Engineering
May 29 - May 30, 2018